Assays for Diagnosing and Evaluating Treatment Options for Fabry Disease
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 60/801,089, filed May 16, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,851,143 | Assays for Diagnosing and Evaluating Treatment Options for Fabry Disease In force · High confidence UsedRemaining | BPCR Limited Partnership | In force | High confidence | ||
| US 9,000,011 | Methods for Treatment of Fabry Disease In force · Medium confidence | BPCR Limited Partnership | In force | Medium confidence | ||
| US 9,480,682 | Methods for Treatment of Fabry Disease In force · Low confidence | BPCR Limited Partnership | In force | Low confidence | ||
| US 9,987,263 | Methods for Treatment of Fabry Disease In force · Low confidence | BPCR Limited Partnership | In force | Low confidence | ||
| US 10,383,864 | Methods for Treatment of Fabry Disease In force · Low confidence | BPCR Limited Partnership | In force | Low confidence | ||
| US 10,406,143 | Methods for Treatment of Fabry Disease In force (reinstated) · Low confidence | BPCR Limited Partnership | In force (reinstated) | Low confidence | ||
| US 11,241,422 | Methods for Treatment of Fabry Disease In force · Low confidence | BPCR Limited Partnership | In force | Low confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.